Heghine Khachatryan: What Is Your Position on the Voluntary or Financially Compensated Blood Donation Model
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:
“Blood donation remains one of the most essential pillars of modern healthcare.
Yet, the sustainability of blood supplies continues to challenge healthcare systems worldwide, raising important ethical and practical questions.
As healthcare professionals, researchers, and transfusion specialists, your perspective is invaluable.
Discussion Question
Should blood donation remain a completely voluntary, non-remunerated act, or should financial compensation for donors be considered under specific circumstances?
Please share your opinion and the reasoning behind it.
Option 1 – Voluntary, Non-Remunerated Blood Donation (Supported by WHO)
- Promotes altruism, solidarity, and public trust.
- Is generally associated with the lowest risk of transfusion-transmissible infections.
- Reduces the possibility that financial need may influence donor eligibility or disclosure of risk factors.
- Supports a sustainable culture of regular, repeat voluntary donors.
Option 2 – Financially Compensated Donation
- May increase donor recruitment during periods of blood shortages.
- Could improve the availability of plasma or blood components in regions facing chronic supply deficits.
- May acknowledge the donor’s time, travel expenses, and inconvenience.
- Raises ethical concerns regarding equity, exploitation of economically vulnerable populations, and potential impacts on donor safety and blood quality.
There is no universally simple answer. Different countries have adopted different models, each with unique ethical, clinical, and public health implications.
What is your position?
- I support exclusively voluntary, non-remunerated donation.
- I support carefully regulated financial compensation.
- I believe a hybrid model is the most appropriate.
Please explain the evidence, ethical principles, or clinical experience that has shaped your opinion. An open, respectful discussion can help advance transfusion medicine and strengthen future blood donation policies.”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia
-
Aug 23, 2026, 16:03Balaji Balagani: Major Causes of Sudden Cardiac Death in Children
-
Aug 23, 2026, 16:02Bartosz Hudzik: What’s Hot at ESC Congress 2026